Kenneth L. McClain

Active 1983–2025

80
Papers
22,809
Citations
64
h-index
79
i10-index

Citations

Citations per year for Kenneth L. McClain1984: 2 citations1985: 5 citations1986: 9 citations1987: 8 citations1988: 10 citations1989: 15 citations1990: 9 citations1991: 20 citations1992: 17 citations1993: 12 citations1994: 26 citations1995: 31 citations1996: 40 citations1997: 26 citations1998: 45 citations1999: 31 citations2000: 51 citations2001: 35 citations2002: 28 citations2003: 28 citations2004: 26 citations2005: 29 citations2006: 40 citations2007: 36 citations2008: 41 citations2009: 41 citations2010: 63 citations2011: 58 citations2012: 78 citations2013: 87 citations2014: 171 citations2015: 151 citations2016: 97 citations2017: 165 citations2018: 142 citations2019: 461 citations2020: 628 citations2021: 572 citations2022: 352 citations2023: 295 citations2024: 578 citations2025: 160 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,241 citing papers, 27.5% of this breakdownChina: 296 citing papers, 6.6% of this breakdownUnited Kingdom: 286 citing papers, 6.3% of this breakdownFrance: 276 citing papers, 6.1% of this breakdownGermany: 262 citing papers, 5.8% of this breakdownItaly: 252 citing papers, 5.6% of this breakdownCanada: 172 citing papers, 3.8% of this breakdownJapan: 139 citing papers, 3.1% of this breakdownNetherlands: 137 citing papers, 3% of this breakdownSweden: 121 citing papers, 2.7% of this breakdownAustria: 91 citing papers, 2% of this breakdownSpain: 86 citing papers, 1.9% of this breakdown
0%27.5%Other 25.6%

Fields

  • Medicine85.5%
  • Immunology and Microbiology9.9%
  • Biochemistry, Genetics and Molecular Biology3.7%
  • Neuroscience0.4%
  • Computer Science0.2%
  • Other0.3%

Topics

  • Autoimmune and Inflammatory Disorders Research12.7%
  • Immune Cell Function and Interaction8.3%
  • Histiocytic Disorders and Treatments7.3%
  • Parvovirus B19 Infection Studies7%
  • Viral-associated cancers and disorders6.2%
  • Immunodeficiency and Autoimmune Disorders3.9%
  • Other54.6%

Coauthors

All papers

Open in search
  1. HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

    Authors: , , , , , , , , , , - Pediatric Blood & Cancer 2006 cited by 5,301

  2. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study

    Authors: , , , , , , , , , , , , , , , - Blood 2017 cited by 661

  3. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph D. P. Willet, David Swan, Yaobo Xu, Mauro Santibanez‐Koref, Voytek Slowik, Darrell L. Dinwiddie, Christina E. Ciaccio, Carol Saunders, Seth Septer, Stephen F. Kingsmore, Andrew J. White, Andrew J. Cant, Sophie Hambleton, Megan A. Cooper - Blood 2014 cited by 556

  4. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2020 cited by 401

  5. How I treat hemophagocytic lymphohistiocytosis

    Authors: , , , , - Blood 2011 cited by 1,138

  6. Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO)

    Authors: , , , , , , , , , , , , - Pediatric Blood & Cancer 2019 cited by 417

  7. Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2023 cited by 46

  8. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults

    Authors: , , , , , , , , , , , , , , , , , - Blood 2022 cited by 255

  9. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

    Authors: , , , , , , , , , , , , , , , , , - Blood 2018 cited by 624

  10. Langerhans-Cell Histiocytosis

    Authors: , , - New England Journal of Medicine 2018 cited by 549

  11. Histiocytic disorders

    Authors: , , , , , , , , - Nature Reviews Disease Primers 2021 cited by 153

  12. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2014 cited by 436

  13. BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2021 cited by 79

  14. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2014 cited by 426

  15. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease

    Authors: , , , , , , , , , , , , , , , , - Blood 2014 cited by 586

  16. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jordan S. Orange, Kenneth L. McClain, Carl E. Allen - Blood 2018 cited by 199

  17. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis

    Authors: , , , , , , , , , , , , , , - Blood 2013 cited by 450

  18. A consensus review on malignancy‐associated hemophagocytic lymphohistiocytosis in adults

    Authors: , , , , , , , , , , , - Cancer 2017 cited by 254

  19. IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carl E. Allen - Blood Advances 2021 cited by 61

  20. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis

    Authors: , , , - Pediatric Blood & Cancer 2007 cited by 632

  21. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults

    Authors: , , , , , , , , , , , , , , , , - Blood 2017 cited by 191

  22. Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis

    Authors: , , , , , , , , , , , , , , , - Blood 2016 cited by 169

  23. CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH‐associated neurodegeneration and mass lesions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Geoffrey Murdoch, Julia Kofler, Simon Heales, Marian Malone, Randy Woltjer, Joseph F. Quinn, Paul J. Orchard, Michael C. Kruer, Ronald Jaffe, Markus G. Manz, Sérgio A. Lira, D. Williams Parsons, Miriam Mérad, Tsz‐Kwong Man, Carl E. Allen - Cancer 2018 cited by 134

  24. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab

    Authors: , , , , , , , , , , , , - Pediatric Blood & Cancer 2012 cited by 311